Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
---|---|---|---|---|---|---|---|
Arcellx, Inc. | $56.32 | $2.72 B | -49.3 | 130 | $110.32 M | ||
AnaptysBio, Inc. | $25.18 | $640.07 M | -3.82 | 117 | $17.16 M | ||
Ascendis Pharma A/S | $136.37 | $7.77 B | -14.19 | 879 | $266.72 M | ||
Crinetics Pharmaceuticals, Inc. | $45.45 | $3.53 B | -11.86 | 290 | $4.01 M | ||
Cytokinetics, Incorporated | $54.91 | $6.05 B | -9.78 | 423 | $7.53 M | ||
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 | ||
Dyne Therapeutics, Inc. | $34.60 | $3.03 B | -7.77 | 143 | $0 | ||
Edgewise Therapeutics, Inc. | $20.03 | $1.65 B | -11.47 | 92 | $0 | ||
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M | ||
IDEAYA Biosciences, Inc. | $39.31 | $2.88 B | -19 | 124 | $23.39 M | ||
Inhibrx, Inc. | $13.32 | $241.02 M | -1.44 | 166 | $1.80 M | ||
Kronos Bio, Inc. | $1.19 | $44.62 M | -0.37 | 61 | $6.29 M | ||
Keros Therapeutics, Inc. | $42.86 | $1.76 B | -9.45 | 141 | $151,000 | ||
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 | ||
Lyell Immunopharma, Inc. | $1.50 | $619.50 M | -2.7 | 224 | $130,000 | ||
MeiraGTx Holdings plc | $4.18 | $306.74 M | -4.01 | 402 | $14.02 M | ||
Merus N.V. | $55.83 | $3.50 B | -19.38 | 172 | $43.95 M | ||
Nuvalent, Inc. | $73.64 | $5.11 B | -32.72 | 106 | $0 | ||
Vaxcyte, Inc. | $79.60 | $7.72 B | -16.54 | 254 | $0 | ||
Replimune Group, Inc. | $8.37 | $485.18 M | -2.44 | 331 | $0 | ||
United Therapeutics Corporation | $316.53 | $12.20 B | 13.02 | 1168 | $2.33 B | ||
Viridian Therapeutics, Inc. | $12.49 | $776.72 M | -2.71 | 94 | $314,000 | ||
Ventyx Biosciences, Inc. | $2.24 | $229.83 M | -1.01 | 74 | $0 |